Cardiac manifestations of graft-versus-host disease

Biol Blood Marrow Transplant. 2005 Oct;11(10):773-80. doi: 10.1016/j.bbmt.2005.07.002.

Abstract

Graft-versus-host disease (GVHD) is a major cause of morbidity and mortality after bone marrow transplantation. Well-documented manifestations of GVHD include dermatologic, gastrointestinal, hepatic, pulmonary, musculoskeletal, and hematologic manifestations and sicca syndrome. To date, the heart has only rarely been reported to be a target of GVHD. We report a series of patients who developed bradycardia, coronary artery disease, or cardiomyolysis in association with acute or chronic GVHD. The severity of these manifestations ranged from asymptomatic to fatal. The bradycardias were responsive to increased immunosuppression. Although they are uncommon, it is important to recognize these cardiac manifestations, because they may reflect GVHD activity and may be reversible by increasing immunosuppression.

MeSH terms

  • Adolescent
  • Adult
  • Bone Marrow Transplantation / adverse effects
  • Bone Marrow Transplantation / methods
  • Bradycardia / drug therapy
  • Bradycardia / etiology
  • Cause of Death
  • Child
  • Child, Preschool
  • Coronary Artery Disease / etiology
  • Death, Sudden, Cardiac / etiology
  • Female
  • Graft vs Host Disease / diagnosis*
  • Graft vs Host Disease / etiology
  • Heart Diseases / etiology*
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Hematopoietic Stem Cell Transplantation / methods
  • Humans
  • Immunosuppression Therapy
  • Infant
  • Male
  • Retrospective Studies
  • Steroids / therapeutic use

Substances

  • Steroids